A critical advance in cancer research is emerging with the use of VHH fragments to reactivate damaged p53. This crucial tumor inhibitor protein is frequently disabled in several types of tumors, resulting uncontrolled https://binksites.com/story11902894/vhh-fragments-revive-p53-a-promising-hope-for-cancer-management